Close Menu

NEW YORK – Natera reported after the close of the market on Wednesday a 19 percent increase in third quarter revenues, driven by increased sales of its Panorama noninvasive prenatal and Horizon carrier screening tests.

"Q3 was in many ways a transformational quarter for Natera," said CEO Steve Chapman in a statement. "We continued to see strong momentum in volume growth and improved average selling price per test."

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.